Cardiomyocyte differentiation of rat bone marrow multipotent progenitor cells is associated with downregulation of Oct-4 expression

Tissue Engineering - Part A

Volumn 16, Issue 10, 2010, Pages 3111-3117

  Lu, Tiewei ^a,b   Pelacho, Beatriz ^c   Hao, Hong ^b   Luo, Min ^b   Zhu, Jing ^a   Verfaillie, Catherine M ^c   Tian, Jie ^a   Liu, Zhenguo ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; FLOW CYTOMETRY; FLUORESCENCE; HEART; STEM CELLS;

5-AZACYTIDINE; BONE MARROW; CARDIAC DIFFERENTIATION; CARDIOMYOCYTES; CONNEXIN-43; DOWN-REGULATION; FLOW CYTOMETRY ANALYSIS; IMMUNOFLUORESCENCE STAINING; IN-VITRO; MRNA LEVEL; PROGENITOR CELL; RAT BONE MARROW; SERUM-FREE MEDIUM; TROPONIN I; WESTERN BLOTTING;

POLYMERASE CHAIN REACTION;

RATTUS;

AZACITIDINE; CONNEXIN 43; HOMEODOMAIN PROTEIN; NKX2.5 PROTEIN, RAT; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TROPONIN I;

ANIMAL; ARTICLE; BONE MARROW CELL; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HEART MUSCLE CELL; METABOLISM; MULTIPOTENT STEM CELL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; AZACITIDINE; BLOTTING, WESTERN; BONE MARROW CELLS; CONNEXIN 43; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GATA4 TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEINS; MULTIPOTENT STEM CELLS; MYOCYTES, CARDIAC; OCTAMER TRANSCRIPTION FACTOR-3; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TROPONIN I;

EID: 77957655376     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0036     Document Type: Article

References (30)

1. Garć?a-Castro, J., Trigueros, C., Madrenas, J., Pérez-Simón, J.A., Rodriguez, R., and Menendez, P. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med 12, 2552, 2008.
2. Pittenger, M.F., and Martin, B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9, 2004.
3. Psaltis, P.J., Zannettino, A.C., Worthley, S.G., and Gronthos, S. Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 26, 2201, 2008.
4. Jiang, Y., Vaessen, B., Lenvik, T., Blackstad, M., Reyes, M., and Verfaillie, C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30, 896, 2002.
5. Qi, H., Aguiar, D.J., Williams, S.M., La Pean, A., Pan, W., and Verfaillie, C.M. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci\USA 100, 3305, 2003.
6. Ross, J.J., Hong, Z., Willenbring, B., Zeng, L., Isenberg, B., Lee, E.H., Reyes, M., Keirstead, S.A., Weir, E.K., Tranquillo, R.T., and Verfaillie, C.M. Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J Clin Invest. 116, 3139, 2006.
7. Breyer, A., Estharabadi, N., Oki, M., Ulloa, F., Nelson-Holte, M., Lien, L., and Jiang, Y. Multipotent adult progenitor cell isolation and culture procedures. Exp Hematol 34, 1596, 2006.
8. Ulloa-Montoya, F., Kidder, B.L., Pauwelyn, K.A., Chase, L.G., Luttun, A., Crabbe, A., Geraerts, M., Sharov, A.A., Piao, Y., Ko, M.S., Hu, W.S., and Verfaillie, C.M. Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol 8, 1, 2007.
9. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W.C., Largaespada, D.A., and Verfaillie, C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41, 2002.
10. Pelacho, B., Luttun, A., Aranguren, X.L., Verfaillie, C.M., and Prósper, F. Therapeutic potential of adult progenitor cells in cardiovascular disease. Expert Opin Biol Ther 7, 1153, 2007.
11. Tolar, J., Wang, X., Braunlin, E., McElmurry, R.T., Naka-mura, Y., Bell, S., Xia, L., Zhang, J., Hu, Q., Panoskaltsis-Mortari, A., Zhang, J., and Blazar, B.R. The host immune response is essential for the beneficial effect of adult stem cells after myocardial ischemia. Exp Hematol 35, 682, 2007.
12. Feng, C., Zhu, J., Zhao, L., Lu, T., Zhang, W., Liu, Z., and Tian, J. Suberoylanilide hydroxamic acid promotes cardio-myocyte differentiation of rat mesenchymal stem cells. Exp Cell Res 315, 3044, 2009.
13. Chu, L., Jiang, Y., Hao, H., Xia, Y., Xu, J., Liu, Z., Verfaillie, C.M., Zweier, J.L., and Liu, Z. Nitric oxide enhances Oct-4 expression in bone marrow stem cells and promotes endo-thelial differentiation. Eur J Pharmacol 591, 59, 2008.
14. Luczak, M.W., and Jagodziński, P.P. The role of DNA methylation in cancer development. Folia Histochem Cyto-biol 44, 143, 2006.
15. Xu, C., Police, S., Rao, N., and Carpenter, M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cell. Circ Res 91, 501, 2002.
16. Choi, S.C., Yoon, J., Shim, W.J., Ro, Y.M., and Lim, D.S. 5-Azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med 36, 515, 2004.
17. Antonitsis, P., Ioannidou-Papagiannaki, E., Kaidoglou, A., Charokopos, N., Kalogeridis, A., Kouzi-Koliakou, K., Kyriakopoulou, I., Klonizakis, I., and Papakonstantinou, C. Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro. Thorac Cardiovasc Surg 56, 77, 2008.
18. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103, 697, 1999.
19. Martin-Rendon, E., Sweeney, D., Lu, F., Girdlestone, J., Navarrete, C., and Watt, S.W. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardio-myocytes in vitro at high frequencies. Vox Sang 95, 137, 2008.
20. Anjos-Afonso, F., and Bonnet, D. Nonhematopoietic/endothelial SSEA-1\+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 109, 1298, 2007.
21. Zhang, S., Ge, J., Sun, A., Xu, D., Qian, J., Lin, J., Zhao, Y., Hu, H., Li, Y., Wang, K., and Zou, Y. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem 99, 1132, 2006.
22. Tomita, S., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.J., Sakai, T., and Jia, Z.Q. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100, 247, 1999.
23. Niwa, H., Miyazaki, J., and Smith, A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24, 372, 2000.
24. Pesce, M., and Schöler, H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19, 271, 2001.
25. Kim, J.B., Sebastiano, V., Wu, G., Araúzo-Bravo, M.J., Sasse, P., Gentile, L., Ko, K., Ruau, D., Ehrich, M., van den Boom, D., Meyer, J., Hü bner, K., Bernemann, C., Ortmeier, C., Zenke, M., Fleischmann, B.K., Zaehres, H., and Schöler, H.R. Oct4-induced pluripotency in adult neural stem cells. Cell 136, 411, 2009.
26. Kim, J.B., Greber, B., Araú zo-Bravo, M.J., Meyer, J., Park, K.I., Zaehres, H., and Schöler, H.R. Direct reprogramming of human neural stem cells by OCT4. Nature 461, 649, 2009.
27. Xu, J., Liu, X., Jiang, Y., Chu, L., Hao, H., Liua, Z., Ver-faillie, C., Zweier, J., Gupta, K., and Liu, Z. MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. J Cell Mol Med 12, 2395, 2008.
28. Balana, B., Nicoletti, C., Zahanich, I., Graf, E.M., Christ, T., Boxberger, S., and Ravens, U. 5-Azacytidine induces changes in electrophysiological properties of human mesenchy-mal stem cells. Cell Res 16, 949, 2006.
29. Rose, R.A., Jiang, H., Wang, X., Helke, S., Tsoporis, J.N., Gong, N., Keating, S.C., Parker, T.G., Backx, P.H., and Keating, A. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells 26, 2884, 2008.
30. Miquerol, L., Dupays, L., Théveniau-Ruissy, M., Alcoléa, S., Jarry-Guichard, T., Abran, P., and Gros, D. Gap junctional connexins in the developing mouse cardiac conduction system. Novartis Found Symp 250, 80, 2003.